AI mental health support for cancer patients
Part of Cancer clinical trials.
This study is testing an interactive AI-based service to support the mental health of people with cancer. It is designed to help during or after cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with cancer (a malignant tumor).
- You must currently be getting treatment for your cancer, or have finished treatment and are just having regular follow-up check-ups.
- You must be able to understand questions and give your consent to join this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an AI-powered chatbot can help people with cancer feel better emotionally and improve their quality of life. You can join if you are currently in cancer treatment, feeling distressed, and have a smartphone.
This study tests a digital avatar that helps you learn about your cancer treatment. It aims to make understanding your treatment easier and more interactive, helping you feel more prepared.
This study is testing a chatbot that provides emotional support to adults recently diagnosed with cancer. It aims to help you manage stress and anxiety during early treatment.
This study is testing a new AI chatbot that gives support after breast cancer treatment. If you join, you'll chat with the bot on Line to help with your recovery.
This trial uses artificial intelligence to understand how cancer patients are feeling emotionally, which could help doctors provide better support. Participants will answer some questionnaires and have their responses analyzed by AI.
This trial tests if an AI chatbot can help people with a diagnosed mental illness. It aims to find a new way to support your mental health.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.